This inventor holds 2 USPTO granted patents. Top assignee: Biomendics, LLC. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Emily L Plocinik: Innovator in Antimicrobial Formulations
Introduction
Emily L Plocinik is a notable inventor based in Rootstown, OH (US). She has made significant contributions to the field of antimicrobial formulations, focusing on methods to combat microbial colonization. Her innovative work has implications for various applications in health and safety.
Latest Patents
Emily holds a patent for "Substituted tolans for the modulation of microbial colonization." This patent describes methods for disinfecting physical or biological surfaces using an antimicrobial formulation that includes substituted tolan compounds. The substitutions may include alkoxy groups, such as methoxy, and hydroxy substituents on one or both phenyl rings of the tolan. The compounds and methods can be either static or cidal, depending on the dosage and the type of microbe involved. The suspected pathogenic microbes targeted by her invention include Gram-negative bacteria, Gram-positive bacteria such as MRSA, and fungal pathogens like those in the Candida genus. Additionally, her patent outlines methods for inhibiting or disrupting biofilm formation of various microbes.
Career Highlights
Emily is associated with Biomendics, LLC, where she applies her expertise in antimicrobial research. Her work is pivotal in developing effective solutions to combat microbial threats in various environments.
Collaborations
Emily has collaborated with notable colleagues, including Karen M McGuire and Chun-che Tsai. These partnerships have enhanced her research and contributed to the advancement of her innovative solutions.
Conclusion
Emily L Plocinik is a pioneering inventor whose work in antimicrobial formulations is making a significant impact in the field. Her patent on substituted tolans showcases her commitment to addressing microbial challenges effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile